Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose
- PMID: 14573630
- PMCID: PMC219580
- DOI: 10.1128/IAI.71.11.6148-6154.2003
Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose
Abstract
A major problem in the study of chlamydial genital infections in animal models has been the use of varied doses of chlamydiae for infection in different laboratories. It is clearly desirable to use a dose which approximates that of natural sexual infection, but that dose to date has not been determined because of the inability of researchers to quantify chlamydiae in semen. Fortunately, sexual transmission of chlamydiae has been described for the guinea pig model of infection with the chlamydial agent of guinea pig inclusion conjunctivitis (GPIC). In this study, we undertook to determine the approximate infection dose in actual sexual transmission by comparing the kinetics of infection in female guinea pigs acquired via sexual contact to those of genital infections induced artificially with known quantities of chlamydiae. Groups of guinea pigs were infected intravaginally with 10(4), 10(3), 10(2), and 10(1) inclusion-forming units (IFU) of GPIC, and the kinetics of the infection were determined. Infection with 10(2) IFU produced infections with lower peak levels than those in animals receiving 10(4) or 10(3) IFU. Seventy percent of animals receiving 10(2) IFU became infected, while 100 and 79% of animals receiving 10(4) and 10(3) IFU, respectively, became infected. Animals receiving 10(2) IFU also had a longer incubation period. Of 19 animals that mated with infected males, 63.2% became infected, with an infection course which was not significantly different than that of the 10(2)-IFU-infected group. The data suggest that female guinea pigs received approximately 10(2) IFU by sexual transmission. Of interest was the observation that the guinea pigs infected by sexual transmission shed organisms for a significantly shorter time period than that of any group that was artificially infected. This result suggests that there may be factors associated with semen which passively transfer antimicrobial activity to the female or enhance the innate host response in the female. Immunization of females with an inactivated vaccine was also found to elicit a protective immune response against sexual challenge, demonstrating that the model can be used in the evaluation of possible vaccine candidates and/or methodologies. There is currently no other animal model available for any sexually transmitted disease in which the disease or the ability to prevent the disease may be studied in animals infected by the natural means.
Figures




Similar articles
-
Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes.Infect Immun. 1990 Aug;58(8):2599-605. doi: 10.1128/iai.58.8.2599-2605.1990. Infect Immun. 1990. PMID: 2370110 Free PMC article.
-
Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis.Sex Transm Dis. 1996 Mar-Apr;23(2):145-50. doi: 10.1097/00007435-199603000-00010. Sex Transm Dis. 1996. PMID: 8919742
-
Cystitis associated with chlamydial infection of the genital tract in male guinea pigs.Sex Transm Dis. 1981 Jul-Sep;8(3):203-10. doi: 10.1097/00007435-198107000-00006. Sex Transm Dis. 1981. PMID: 7292213
-
Chlamydia trachomatis: impact on human reproduction.Hum Reprod Update. 1999 Sep-Oct;5(5):433-47. doi: 10.1093/humupd/5.5.433. Hum Reprod Update. 1999. PMID: 10582782 Review.
-
Vaccines for Chlamydia infections of the female genital tract.Future Microbiol. 2008 Feb;3(1):67-77. doi: 10.2217/17460913.3.1.67. Future Microbiol. 2008. PMID: 18230035 Review.
Cited by
-
Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.Metabolomics. 2016 Apr;12(4):74. doi: 10.1007/s11306-016-0998-5. Epub 2016 Mar 8. Metabolomics. 2016. PMID: 27642272 Free PMC article.
-
The guinea pig as a model of infectious diseases.Comp Med. 2008 Aug;58(4):324-40. Comp Med. 2008. PMID: 18724774 Free PMC article. Review.
-
Phosphoproteomic analysis of the Chlamydia caviae elementary body and reticulate body forms.Microbiology (Reading). 2015 Aug;161(8):1648-1658. doi: 10.1099/mic.0.000116. Epub 2015 May 21. Microbiology (Reading). 2015. PMID: 25998263 Free PMC article.
-
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies.Microorganisms. 2021 Apr 30;9(5):975. doi: 10.3390/microorganisms9050975. Microorganisms. 2021. PMID: 33946391 Free PMC article.
-
Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.Infect Immun. 2019 Jun 20;87(7):e00834-18. doi: 10.1128/IAI.00834-18. Print 2019 Jul. Infect Immun. 2019. PMID: 30833332 Free PMC article.
References
-
- Ahmad, A., C. R. Dawson, C. Yoneda, B. Togni, and J. Schachter. 1977. Resistance to reinfection with a chlamydial agent (guinea pig inclusion conjunctivitis). Investig. Ophthalmol. Vis. Sci. 16:549-553. - PubMed
-
- Barron, A. L., H. J. White, R. G. Rank, B. L. Soloff, and E. B. Moses. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66. - PubMed
-
- Batteiger, B. E., R. G. Rank, P. M. Bavoil, and L. S. F. Soderberg. 1993. Partial protection against reinfection by immunization of guinea pigs with isolated outer-membrane proteins of the chlamydial agent of guinea pig inclusion conjunctivitis. J. Gen. Microbiol. 139:2965-2972. - PubMed
-
- Com, E., F. Bourgeon, B. Evrard, T. Ganz, D. Colleu, B. Jegou, and C. Pineau. 2003. Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol. Reprod. 68:95-104. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical